Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review - Wikidata - awgldk - TriplyDB

Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review

Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review

http://www.wikidata.org/entity/Q24678961

about

Paclitaxel targets VEGF-mediated angiogenesis in ovarian cancer treatment Pre-clinical drug prioritization via prognosis-guided genetic interaction networks An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer.Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials Antiproliferative and apoptotic effects of Sesbania grandiflora leaves in human cancer cells PI3K Inhibition Augments the Therapeutic Efficacy of a 3a-aza-Cyclopenta[α]indene Derivative in Lung Cancer Cells Cancer imaging: is it cost-effective?The lung cancer paradox: time for action.Docetaxel in non-small cell lung cancer: a review.Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles.Genome-wide Association Study on Platinum-induced Hepatotoxicity in Non-Small Cell Lung Cancer Patients.A Novel, Potent, Small Molecule AKT Inhibitor Exhibits Efficacy against Lung Cancer Cells In Vitro Combination therapy versus single agent chemotherapy in non-small cell lung cancer.Association between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non-Small Cell Lung Cancer Cells.Impact of anticancer drugs price cut on physician's prescription choices on first-line chemotherapy regimens and health expenditure for advanced non-small cell lung cancer in China Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer.Analysis of economic evaluations of pharmacological cancer treatments in Spain between 1990 and 2010.A systematic review of economic evaluations in second and later lines of therapy for the treatment of non-small cell lung cancer.The role of dietary nutrition in stomach cancer.Is gemcitabine cost effective in cancer treatment?Development of Chitosan-based Dry Powder Inhalation System of Cisplatin for Lung Cancer.The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.Docetaxel increases the risk of severe infections in the treatment of non-small cell lung cancer: a meta-analysis

P2860

Q28073057-C0EBCC72-3A29-4154-B4E6-4FA1056BBCBD Q28476072-3BC09DDD-5A80-41C2-94B3-A853B52FC4CD Q33393471-37A7A2CB-0C01-4B2D-904C-AF1A2FADF75C Q33436415-FA1A32F0-8C08-4806-917E-3EAA844B3FBF Q33739831-D4D30D3C-8C57-4E98-B3CA-3013DB34FCE8 Q33912340-E452326A-D47D-481A-AF00-ACC9BF55FAE3 Q34533328-D82CE4F3-409D-40A5-B8DE-92C5C4D44F26 Q34938656-97538BEB-EC85-4D9A-BB6F-164E9892185A Q35095221-63439B02-1A5D-4937-A68E-7C7D180B0C03 Q35537773-FF0E56D7-AF38-47FC-9DEE-10CA0599DEE9 Q35602780-0C557843-31AF-47B5-83D6-84340FEB4681 Q35769777-9AF21C9C-5FBB-47A3-8A3D-CEA5AF079204 Q36187059-EE0AF4D0-ED4D-4798-BAA8-9D1A3B528EC7 Q36222050-3EF9EF55-EC64-486F-968F-9AFA80419BB2 Q36629248-1BE7095A-87FB-4330-9B7D-B9A03811EF26 Q36823866-BE1A5BC3-99FC-4095-968A-B02503F68C9F Q37411137-F702FE60-1F64-497D-8F11-CFADDE8206CE Q37902246-6235B390-7288-48DA-B8BC-C9CA88D307D3 Q38062490-5D2B9B16-1494-493B-8188-2D253B67D6E4 Q38074876-4C510C99-FE79-4D72-B824-C7B073A30ABA Q38193079-C038B836-6F66-4505-BE9A-5B5A02B214C3 Q43042833-A2B6A9BD-5A49-4466-B172-E19EA0FBB8B7 Q43120677-4BC55067-03D8-43FC-8F78-B8B5E1BC89FD Q52565567-DC6BD346-8964-4708-90AD-50E6E036381D Q58718145-E7698598-B00A-44A9-868B-7B088918C2AC

P2860

Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review

http://www.wikidata.org/entity/Q24678961

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Clinical and cost effectivenes ...... ng cancer: a systematic review

@ast

Clinical and cost effectivenes ...... ng cancer: a systematic review

@en

Clinical and cost effectivenes ...... ng cancer: a systematic review

@nl

type

label

Clinical and cost effectivenes ...... ng cancer: a systematic review

@ast

Clinical and cost effectivenes ...... ng cancer: a systematic review

@en

Clinical and cost effectivenes ...... ng cancer: a systematic review

@nl

prefLabel

Clinical and cost effectivenes ...... ng cancer: a systematic review

@ast

Clinical and cost effectivenes ...... ng cancer: a systematic review

@en

Clinical and cost effectivenes ...... ng cancer: a systematic review

@nl

P1433

Q24678961-BFA30970-0DCF-46CE-A26A-BCF3015B965F

P1476

Q24678961-0B2A02CA-B421-424C-8081-9B9589E9606A

P2093

Q24678961-11A4F6F4-4F4F-44C8-8B31-6953F641F2B7

Q24678961-74791D8D-255C-42D3-B97E-3EB778E17BBF

Q24678961-CDDA44F7-CC13-438C-BE43-0E6C83267067

Q24678961-E66DC2F8-683B-4E2D-869D-6B06DF1B4BD9

P2860

Q24678961-0A9B06FA-F1D5-48EA-A799-E9994B53B9D7

Q24678961-0DE772C7-A1B4-4277-8CA5-5A3DE20305B3

Q24678961-173C5689-04B8-4B9E-875A-02AE71D87224

Q24678961-1960E0A3-12A1-496C-9470-60123AE9A39D

Q24678961-19868229-160B-4FB6-BD85-ED933B1DF630

Q24678961-1D5C4A5D-06E7-46E2-AA5D-3CF811E5C854

Q24678961-219497BC-BF6B-4C22-819F-093FB7E9A858

Q24678961-251F2FCF-D265-4DD9-A874-A5919F55B7D0

Q24678961-2BB7E69D-D122-430C-A6E8-39C570EBD7A4

Q24678961-33C77AC5-541C-4147-890D-1319E723DB51

P304

Q24678961-C4F03775-B41F-4D61-88E4-9A711E34F92E

P31

Q24678961-7E98E923-2C0D-4A7F-89C8-2AF371DD9FAD

Q24678961-9D69513B-84E5-43B9-AB2C-8EBD848B9A84

P3181

Q24678961-FB66388E-29EA-465A-81F5-3EB183CF03F6

P356

Q24678961-0E325BAB-0A8B-43F5-813F-F081C611A993

P407

Q24678961-0AA70443-659F-4970-953A-D0C23C9F4211

P433

Q24678961-A915C0B3-D34A-4BAE-BFBE-054EE361CB36

P478

Q24678961-E0EE513A-2D69-43D0-8E91-E64636E1F7D3

P50

Q24678961-CECD9BFF-99DA-4E1F-A478-34374AE08EFD

P577

Q24678961-CFC597E2-F8F7-433E-AF40-BD28571C1533

P5875

Q24678961-3CB74ED6-3351-4AA1-845C-5263EA895B32

P698

Q24678961-DEE0954D-54C3-4E0E-A764-E672112BB8AC

P932

Q24678961-C4E5B142-BADA-46FD-953A-790A436F0C98

P3181

P356

P1433

P1476

Clinical and cost effectivenes ...... ng cancer: a systematic review

@en

P2093

A Clegg

http://www.w3.org/2001/XMLSchema#string

M Sidhu

http://www.w3.org/2001/XMLSchema#string

N Waugh

http://www.w3.org/2001/XMLSchema#string

P Hewitson

http://www.w3.org/2001/XMLSchema#string

P2860

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

The hazards of scoring the quality of clinical trials for meta-analysis

Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer.

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.

Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer.

Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology Group.

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.

Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.

P304

20-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

5096832

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/THORAX.57.1.20

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276941946

http://www.w3.org/2001/XMLSchema#string

P698

11809985

http://www.w3.org/2001/XMLSchema#string

P932

1746188

http://www.w3.org/2001/XMLSchema#string